Women executives who reach the top in finance are reshaping the profession while creating newfound value for their companies, ...

India’s CRDMO market, currently holding 2-3% of the global share, has the potential to reach $22-25 billion by 2035, says a ...

The students, thereafter, knocked at the doors of Gujarat HC which ordered the BCG to issue the certificate to the students ...

ImmunityBio has gained US Food and Drug Administration (FDA) authorisation for an expanded access programme to supply an ...

India currently holds a 2-3 per cent share of the USD 140-145 billion global CRDMO market but has the potential to become a ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA ...

Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of ...

The Indian Contract Research, Development, and Manufacturing Organization (CRDMO) sector is at an inflection point, with the potential to grow to $22 - $25 billion by 2035, according to a new report, ...

BCG predicts rising temperatures will increase default risk in 30% of agri and housing loans by 2030, highlighting climate ...

Innovative research at Weill Cornell Medicine introduces engineered mycobacteria strains with 'kill switches' for safer TB ...

A new BCG survey highlights significant dissatisfaction among women with consumer goods, financial services, and healthcare ...

FDA approves an expanded access program that would offer patients an alternative to Merck’s bladder cancer medication.